State of Wisconsin Investment Board’s Relmada Therapeutics RLMD Stock Holding History

State of Wisconsin Investment Board’s Portfolio RLMD Stock Details RLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,898	Closed	-$885K	–	2629
2022 Q3	$885K	Sell	23,898 -578	-2%	-$16K	﹤0.01%	1599
2022 Q2	$465K	Buy	24,476 +3,576	+17%	+$78K	﹤0.01%	2105
2022 Q1	$564K	Buy	+20,900	New	+$432K	﹤0.01%	1769
2021 Q4	–	Sell	-20,100	Closed	-$527K	–	2201
2021 Q3	$527K	Hold	20,100	–	–	﹤0.01%	1679
2021 Q2	$643K	Hold	20,100	–	–	﹤0.01%	1606
2021 Q1	$708K	Hold	20,100	–	–	﹤0.01%	1466
2020 Q4	$645K	Sell	20,100 -2,500	-11%	-$85.9K	﹤0.01%	1450
2020 Q3	$850K	Hold	22,600	–	–	﹤0.01%	1331
2020 Q2	$1.01M	Buy	+22,600	New	+$955K	﹤0.01%	1240

Other funds holding RLMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Wisconsin Investment Board's RLMD Position: Q4 2022 in Review

State of Wisconsin Investment Board sold out of Relmada Therapeutics (RLMD) in Q4 2022, closing a stake of 23,898 shares — an estimated $885K sold.

State of Wisconsin Investment Board first reported a position in RLMD in Q2 2020 and held it in 9 quarters. The position peaked at $1.01M in Q2 2020. 110 funds tracked by Wall St. Rank hold RLMD as of Q4 2022.

State of Wisconsin Investment Board reported no remaining Relmada Therapeutics position as of Q4 2022 after selling out during the quarter.
State of Wisconsin Investment Board sold 23,898 Relmada Therapeutics shares in Q4 2022, an estimated $885K.
State of Wisconsin Investment Board first reported a position in Relmada Therapeutics in Q2 2020 and held it in 9 quarters.
State of Wisconsin Investment Board's Relmada Therapeutics position peaked at $1.01M in Q2 2020.
110 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q4 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2022, filed 14 Feb 2023.